Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Trial to Assess the Performance of Centralized Assay Solutions for Detection of MTB and Resistance to Rifampin and Isoniazid

NCT04147676 is registered in ClinicalTrials.gov with Foundation for Innovative New Diagnostics, Switzerland as lead sponsor.

NCT NCT04147676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04147676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Trial to Assess the Performance of Centralized Assay Solutions for Detection of MTB and Resistance to Rifampin and Isoniazid
Lead sponsor
Foundation for Innovative New Diagnostics, Switzerland
Phase
Observational
Overall status
Completed
Start date
May 20, 2019
Completion date
September 1, 2023
Enrollment
1,050 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

drug-resistant tuberculosis, tuberculosis